21 CFR 520.970
§ 520.970 Flunixin.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.970, § 520.970 Flunixin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87164
- Permanent ID
ys:prov:87164@1- SHA-256
e69b4d048d6d22e90a4be8de9020ec6a38920f708540a2298537e4983fe7f7b8
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications.
(1) Each 10-gram (g) packet of granules contains flunixin meglumine equivalent to 250 milligrams (mg) of flunixin.
(2) Each 30-g syringe of paste contains flunixin meglumine equivalent to 1,500 mg of flunixin.
(b) Sponsors. See sponsors in § 510.600(c) of this chapter for use as in paragraph (c) of this section.
(1) No. 000061 for use of products described in paragraph (a).
(2) No. 061133 for use of the product described in paragraph (a)(2).
(c) Conditions of use in horses—(1) Amount. 0.5 mg per pound of body weight per day for up to 5 days.
(2) Indications for use. For alleviation of inflammation and pain associated with musculoskeletal disorders.
(3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.